Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4HPH1
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 11 |
GO:0007031 | peroxisome organization | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.361 |
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.313 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.360 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.649 |
CLV_PCSK_PC1ET2_1 | 176 | 178 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.554 |
DEG_APCC_DBOX_1 | 6 | 14 | PF00400 | 0.397 |
DEG_SPOP_SBC_1 | 18 | 22 | PF00917 | 0.325 |
DOC_CYCLIN_RxL_1 | 139 | 149 | PF00134 | 0.561 |
DOC_MAPK_gen_1 | 125 | 131 | PF00069 | 0.557 |
DOC_MAPK_gen_1 | 176 | 184 | PF00069 | 0.581 |
DOC_MAPK_MEF2A_6 | 157 | 165 | PF00069 | 0.491 |
DOC_MAPK_RevD_3 | 25 | 40 | PF00069 | 0.313 |
DOC_PP1_RVXF_1 | 140 | 146 | PF00149 | 0.520 |
DOC_PP2B_LxvP_1 | 55 | 58 | PF13499 | 0.604 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.555 |
DOC_USP7_UBL2_3 | 95 | 99 | PF12436 | 0.591 |
LIG_14-3-3_CanoR_1 | 16 | 25 | PF00244 | 0.294 |
LIG_14-3-3_CanoR_1 | 177 | 183 | PF00244 | 0.591 |
LIG_14-3-3_CanoR_1 | 46 | 55 | PF00244 | 0.716 |
LIG_14-3-3_CanoR_1 | 6 | 10 | PF00244 | 0.405 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.579 |
LIG_FHA_1 | 179 | 185 | PF00498 | 0.549 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.270 |
LIG_LIR_Gen_1 | 149 | 159 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 149 | 155 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.269 |
LIG_Pex14_1 | 85 | 89 | PF04695 | 0.474 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.237 |
LIG_SUMO_SIM_anti_2 | 181 | 186 | PF11976 | 0.529 |
LIG_SUMO_SIM_anti_2 | 20 | 30 | PF11976 | 0.247 |
LIG_UBA3_1 | 128 | 133 | PF00899 | 0.598 |
MOD_CK1_1 | 20 | 26 | PF00069 | 0.346 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.359 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.354 |
MOD_Cter_Amidation | 77 | 80 | PF01082 | 0.377 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.404 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.573 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.523 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.603 |
MOD_PKA_2 | 5 | 11 | PF00069 | 0.405 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.530 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.396 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.300 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.213 |
MOD_SUMO_rev_2 | 121 | 128 | PF00179 | 0.552 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.494 |
TRG_ER_diArg_1 | 140 | 143 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.606 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 52 | 54 | PF00400 | 0.669 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7N3 | Leptomonas seymouri | 67% | 100% |
A0A0S4JN26 | Bodo saltans | 30% | 100% |
A0A1X0NKF5 | Trypanosomatidae | 41% | 100% |
A0A3S7XB48 | Leishmania donovani | 92% | 100% |
A0A422NM43 | Trypanosoma rangeli | 39% | 100% |
A4ID93 | Leishmania infantum | 92% | 100% |
D0A3I1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
E9AT83 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q1B4 | Leishmania major | 92% | 100% |
V5BKE1 | Trypanosoma cruzi | 37% | 100% |